Page last updated: 2024-10-29

iopromide and Thyrotoxicosis

iopromide has been researched along with Thyrotoxicosis in 1 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beckers, EA1
Strack van Schijndel, RJ1
Weijmer, MC1

Other Studies

1 other study available for iopromide and Thyrotoxicosis

ArticleYear
A contrast crisis.
    Lancet (London, England), 2000, Sep-09, Volume: 356, Issue:9233

    Topics: Adrenocorticotropic Hormone; Contrast Media; Follow-Up Studies; Graves Disease; Humans; Hydrocortiso

2000